MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Iovance Biotherapeutics Total Inventories 2011-2026 | IOVA
Annual Total Inventories Iovance Biotherapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.7 M | 51.5 M | 10.4 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 51.7 M | 10.4 M | 37.9 M |
Quarterly Total Inventories Iovance Biotherapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.7 M | 49.8 M | 65.5 M | 51.5 M | 38.6 M | 27.9 M | 17.6 M | 10.4 M | 9.2 M | 9.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 65.5 M | 9.2 M | 33.2 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Verastem
VSTM
|
1.83 M | $ 5.04 | -4.73 % | $ 349 M |  USA |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |
 |
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | USA |
 |
Avid Bioservices
CDMO
|
30.4 M | - | - | $ 789 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
9.82 M | $ 12.41 | -11.1 % | $ 1.88 B | USA |
 |
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B | USA |
 |
AbbVie
ABBV
|
4.95 B | $ 209.4 | -0.83 % | $ 370 B | USA |
 |
AbCellera Biologics
ABCL
|
6.34 M | $ 3.27 | -2.39 % | $ 977 M |  Canada |
 |
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.21 | -6.2 % | $ 309 M |  Britain |
 |
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 317.36 | -3.29 % | $ 41.6 B | USA |
 |
Aytu BioScience
AYTU
|
11.4 M | $ 2.6 | -2.8 % | $ 16.3 M | USA |